GreenLight Biosciences

What M&A slowdown? Buyers circle GreenLight Biosciences, Egitis Therapeutics
Fierce Biotech
Fri, 03/31/23 - 11:53 am
M&A
GreenLight Biosciences
Egitis Therapeutics
venture capital
Virtually unknown mRNA upstart rides SPAC to Nasdaq with a $1.5B valuation as RA-backed neuro player prices IPO
Endpoints
Tue, 08/10/21 - 10:38 am
GreenLight Biosciences
SPAC
IPOs
MRNA